Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sasha C Appleton

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Seminars in Respiratory and Critical Care Medicine|September 24, 2008
Epidemiology and treatment of multidrug resistant tuberculosisCarole D Mitnick, Sasha C Appleton, Sonya S Shin
AIDS Research and Therapy|October 14, 2011
HIV-free survival and morbidity among formula-fed infants in a prevention of mother-to-child transmission of HIV program in rural HaitiLouise C Ivers, Sasha C Appleton, Bingxia Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 7, 2010
Recurrence after treatment for pulmonary multidrug-resistant tuberculosisMercedes C Becerra, Sasha C Appleton, Molly F Franke, et al.
The Pediatric Infectious Disease Journal|August 29, 2012
Tuberculosis in children exposed at home to multidrug-resistant tuberculosisMercedes C Becerra, Molly F Franke, Sasha C Appleton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2012
Aggressive regimens for multidrug-resistant tuberculosis reduce recurrenceMolly F Franke, Sasha C Appleton, Carole D Mitnick, et al.
Lancet (London, England)|December 15, 2010
Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort studyMercedes C Becerra, Sasha C Appleton, Molly F Franke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2008
Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatmentMolly F Franke, Sasha C Appleton, Jaime Bayona, et al.
Plos One|March 22, 2013
Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortalityCarole D Mitnick, Molly F Franke, Michael L Rich, et al.
The New England Journal of Medicine|August 9, 2008
Comprehensive treatment of extensively drug-resistant tuberculosisCarole D Mitnick, Sonya S Shin, Kwonjune J Seung, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Seminars in Respiratory and Critical Care Medicine|September 24, 2008
Epidemiology and treatment of multidrug resistant tuberculosisCarole D Mitnick, Sasha C Appleton, Sonya S Shin
AIDS Research and Therapy|October 14, 2011
HIV-free survival and morbidity among formula-fed infants in a prevention of mother-to-child transmission of HIV program in rural HaitiLouise C Ivers, Sasha C Appleton, Bingxia Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 7, 2010
Recurrence after treatment for pulmonary multidrug-resistant tuberculosisMercedes C Becerra, Sasha C Appleton, Molly F Franke, et al.
The Pediatric Infectious Disease Journal|August 29, 2012
Tuberculosis in children exposed at home to multidrug-resistant tuberculosisMercedes C Becerra, Molly F Franke, Sasha C Appleton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2012
Aggressive regimens for multidrug-resistant tuberculosis reduce recurrenceMolly F Franke, Sasha C Appleton, Carole D Mitnick, et al.
Lancet (London, England)|December 15, 2010
Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort studyMercedes C Becerra, Sasha C Appleton, Molly F Franke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2008
Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatmentMolly F Franke, Sasha C Appleton, Jaime Bayona, et al.
Plos One|March 22, 2013
Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortalityCarole D Mitnick, Molly F Franke, Michael L Rich, et al.
The New England Journal of Medicine|August 9, 2008
Comprehensive treatment of extensively drug-resistant tuberculosisCarole D Mitnick, Sonya S Shin, Kwonjune J Seung, et al.
Pageof 1